Glucocorticoid receptor transgenic mice as models for depression

Brain Research Reviews

Volumn 57, Issue 2, 2008, Pages 554-560

  Chourbaji, Sabine ^a   Gass, Peter ^a  

^a CENTRAL INSTITUTE OF MENTAL HEALTH   (Germany)

Author keywords

Depression; Glucocorticoid receptor (GR); HPA; Mouse models; Transgenic

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; CORTICOSTERONE; CORTICOTROPIN; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; GLUCOCORTICOID RECEPTOR;

CORTICOTROPIN RELEASE; CUSHING DISEASE; DEPRESSION; DEXAMETHASONE SUPPRESSION TEST; ELECTROCONVULSIVE THERAPY; FORCED SWIMMING TEST; FOREBRAIN; GENE MUTATION; HYPERACTIVITY; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; KNOCKOUT MOUSE; MOUSE; NEGATIVE FEEDBACK; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; REVIEW; STRESS; TRANSGENIC MOUSE;

ANIMALS; DEPRESSION; DISEASE MODELS, ANIMAL; HUMANS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; MICE; MICE, TRANSGENIC; PITUITARY-ADRENAL SYSTEM; RECEPTORS, GLUCOCORTICOID; STRESS, PSYCHOLOGICAL;

EID: 40749100186     PISSN: 01650173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainresrev.2007.04.008     Document Type: Review

References (52)

1. Altar C.A. Neurotrophins and depression. Trends Pharmacol. Sci. 20 2 (1999) 59-61
2. Arborelius L., Owens M.J., Plotsky P.M., and Nemeroff C.B. The role of corticotropin-releasing factor in depression and anxiety disorders. J. Endocrinol. 160 (1999) 1-12
3. Barden N. Modulation of glucocorticoid receptor gene expression by antidepressant drugs. Pharmacopsychiatry 29 1 (1996) 12-22
4. Barden N., Stec I.S., Montkowski A., Holsboer F., and Reul J.M. Endocrine profile and neuroendocrine challenge tests in transgenic mice expressing antisense RNA against the glucocorticoid receptor. Neuroendocrinology 66 3 (1997) 212-220
5. Beato M., Herrlich P., and Schütz G. Steroid hormone receptors: many actors in search of a plot. Cell 83 (1995) 851-857
6. Beaulieu S., Rousse I., Gratton A., Barden N., and Rochford J. Behavioral and endocrine impact of impaired type II glucocorticoid receptor function in a transgenic mouse model. Ann. N.Y. Acad. Sci. 746 (1994) 388-391
7. Berton O., McClung C.A., Dileone R.J., Krishnan V., Renthal W., Russo S.J., Graham D., Tsankova N.M., Bolanos C.A., Rios M., Monteggia L.M., Self D.W., and Nestler E.J. Essential role of BDNF in the mesolimbic dopamine pathway in social defeat stress. Science 311 5762 (2006) 864-868
8. Biondi M., and Picardi A. Psychological stress and neuroendocrine function in humans: the last two decades of research. Psychother. Psychosom. 68 3 (1999) 114-150
9. Boyle M.P., Brewer J.A., Funatsu M., Wozniak D.F., Tsien J.Z., Izumi Y., and Muglia L.J. Acquired deficit of forebrain glucocorticoid receptor produces depression-like changes in adrenal axis regulation and behavior. Proc. Natl. Acad. Sci. U. S. A. 102 2 (2005) 473-478
10. Boyle M.P., Kolber B.J., Vogt S.K., Wozniak D.F., and Muglia L.J. Forebrain glucocorticoid receptors modulate anxiety-associated locomotor activation and adrenal responsiveness. J. Neurosci. 26 7 (2006) 1971-1978
11. Brown E.S., Rush A.J., and McEwen B.S. Hippocampal remodeling and damage by corticosteroids: implications for mood disorders. Neuropsychopharmacology 21 4 (1999) 474-484
12. Chen Z.Y., Jing D., Bath K.G., Ieraci A., Khan T., Siao C.J., Herrera D.G., Toth M., Yang C., McEwen B.S., Hempstead B.L., and Lee F.S. Genetic variant BDNF (Val66Met) polymorphism alters anxiety-related behavior. Science 314 5796 (2006) 140-143
13. Chourbaji S., Zacher C., Sanchis-Segura C., Dormann C., Vollmayr B., and Gass P. Learned helplessness: validity and reliability of depressive-like states in mice. Brain Res. Brain Res. Protoc. 16 1-3 (2005) 70-78
14. Claes S.J. CRH, stress, and major depression: a psychobiological interplay. Vitam. Horm. 69 (2004) 117-150
15. Cole T.J., Blendy J.A., Monaghan A.P., Krieglstein K., Schmid W., Aguzzi A., Fantuzzi G., Hummler E., Unsicker K., and Schutz G. Targeted disruption of the glucocorticoid receptor gene blocks adrenergic chromaffin cell development and severely retards lung maturation. Genes Dev. 9 13 (1995) 1608-1621
16. Cole T.J., Myles K., Purton J.F., Brereton P.S., Solomon N.M., Godfrey D.I., and Funder J.W. GRKO mice express an aberrant dexamethasone-binding glucocorticoid receptor, but are profoundly glucocorticoid resistant. Mol. Cell. Endocrinol. 173 1-2 (2001) 193-202
17. Cowen P.J. Cortisol, serotonin and depression: all stressed out?. Br. J. Psychiatry 180 (2002) 99-100
18. De Kloet E.R., Vreugdenhil E., Oitzl M.S., and Joels M. Brain corticosteroid receptor balance in health and disease. Endocr. Rev. 19 3 (1998) 269-301
19. Dijkstra I., Tilders F.J., Aguilera G., Kiss A., Rabadan-Diehl C., Barden N., Karanth S., Holsboer F., and Reul J.M. Reduced activity of hypothalamic corticotropin-releasing hormone neurons in transgenic mice with impaired glucocorticoid receptor function. J. Neurosci. 18 10 (1998) 3909-3918
20. Duman R.S., Heninger G.R., and Nestler E.J. A molecular and cellular theory of depression. Arch. Gen. Psychiatry 54 7 (1997) 597-606
21. Gass P., Reichardt H.M., Strekalova T., Henn F., and Tronche F. Mice with targeted mutations of glucocorticoid and mineralocorticoid receptors: models for depression and anxiety?. Physiol. Behav. 73 (2001) 811-825
22. Hatzinger M., Reul J.M.H.M., Landgraf R., Holsboer F., and Neumann I. Combined dexamethasone/CRH test in rats: hypothalamo-pituitary-adrenocortical system alterations in aging. Neuroendocrinolgy 64 (1996) 349-356
23. Hellweg R., Zueger M., Fink K., Hortnagl H., and Gass P. Olfactory bulbectomy in mice leads to increased BDNF levels and decreased serotonin turnover in depression-related brain areas. Neurobiol. Dis. 25 1 (2007) 1-7
24. Heuser I., Yassouridis A., and Holsboer F. The combined dexamethasone/CRH test: a refined laboratory test for psychiatric disorders. J. Psychiatr. Res. 28 4 (1994) 341-356
25. Heuser I.J., Schweiger U., Gotthardt U., Schmider J., Lammers C.H., Dettling M., Yassouridis A., and Holsboer F. Pituitary-adrenal-system regulation and psychopathology during amitriptyline treatment in elderly depressed patients and normal comparison subjects. Am. J. Psychiatry 153 1 (1996) 93-99
26. Holsboer F. The corticosteroid receptor hypothesis of depression. Neuropsychopharmacology 23 5 (2000) 477-501
27. Holsboer F., and Barden N. Antidepressants and hypothalamic-pituitary-adrenocortical regulation. Endocr. Rev. 17 2 (1996) 187-205
28. Karanth S., Linthorst A.C., Stalla G.K., Barden N., Holsboer F., and Reul J.M. Hypothalamic-pituitary-adrenocortical axis changes in a transgenic mouse with impaired glucocorticoid receptor function. Endocrinology 138 8 (1997) 3476-3485
29. Montkowski A., Barden N., Wotjak C., Stec I., Ganster J., Meaney M., Engelmann M., Reul J.M., Landgraf R., and Holsboer F. Long-term antidepressant treatment reduces behavioural deficits in transgenic mice with impaired glucocorticoid receptor function. J. Neuroendocrinol. 7 11 (1995) 841-845
30. Oitzl M.S., Reichardt H.M., Joels M., and de Kloet E.R. Point mutation in the mouse glucocorticoid receptor preventing DNA binding impairs spatial memory. Proc. Natl. Acad. Sci. U. S. A. 98 22 (2001) 12790-12795
31. Opherk C., Tronche F., Kellendonk C., Kohlmuller D., Schulze A., Schmid W., and Schutz G. Inactivation of the glucocorticoid receptor in hepatocytes leads to fasting hypoglycemia and ameliorates hyperglycemia in streptozotocin-induced diabetes mellitus. Mol. Endocrinol. 18 6 (2004) 1346-1353
32. Pariante C.M. The glucocorticoid receptor: part of the solution or part of the problem?. J. Psychopharmacol. 20 4 Suppl (2006) 79-84
33. Pepin M.C., Govindan M.V., and Barden N. Increased glucocorticoid receptor gene promoter activity after antidepressant treatment. Mol. Pharmacol. 41 6 (1992) 1016-1022
34. Pepin M.C., Pothier F., and Barden N. Impaired type II glucocorticoid-receptor function in mice bearing antisense RNA transgene. Nature 355 6362 (1992) 725-728
35. Reichardt H.M., Umland T., Bauer A., Kretz O., and Schutz G. Mice with an increased glucocorticoid receptor gene dosage show enhanced resistance to stress and endotoxic shock. Mol. Cell. Biol. 20 23 (2000) 9009-9017
36. Reul J.M., Gesing A., Droste S., Stec I.S., Weber A., Bachmann C., Bilang-Bleuel A., Holsboer F., and Linthorst A.C. The brain mineralocorticoid receptor: greedy for ligand, mysterious in function. Eur. J. Pharmacol. 405 1-3 (2000) 235-249
37. Ridder S., Chourbaji S., Hellweg R., Urani A., Zacher C., Schmid W., Zink M., Hortnagl H., Flor H., Henn F.A., Schutz G., and Gass P. Mice with genetically altered glucocorticoid receptor expression show altered sensitivity for stress-induced depressive reactions. J. Neurosci. 25 26 (2005) 6243-6250
38. Rochford J., Beaulieu S., Rousse I., Glowa J.R., and Barden N. Behavioral reactivity to aversive stimuli in a transgenic mouse model of impaired glucocorticoid (type II) receptor function: effects of diazepam and FG-7142. Psychopharmacology (Berl) 132 2 (1997) 145-152
39. Schulte-Herbruggen O., Chourbaji S., Muller H., Danker-Hopfe H., Brandwein C., Gass P., and Hellweg R. Differential regulation of nerve growth factor and brain-derived neurotrophic factor in a mouse model of learned helplessness. Exp. Neurol. 202 2 (2006) 404-409
40. Schulte-Herbruggen O., Chourbaji S., Ridder S., Brandwein C., Gass P., Hortnagl H., and Hellweg R. Stress-resistant mice overexpressing glucocorticoid receptors display enhanced BDNF in the amygdala and hippocampus with unchanged NGF and serotonergic function. Psychoneuroendocrinology 31 10 (2006) 1266-1277
41. Schulte-Herbruggen O., Hellweg R., Chourbaji S., Ridder S., Brandwein C., Gass P., and Hortnagl H. Differential regulation of neurotrophins and serotonergic function in mice with genetically reduced glucocorticoid receptor expression. Exp. Neurol. 204 1 (2007) 307-316
42. Steckler T., and Holsboer F. Enhanced conditioned approach responses in transgenic mice with impaired glucocorticoid receptor function. Behav. Brain Res. 102 (1999) 151-163
43. Strohle A., Poettig M., Barden N., Holsboer F., and Montkowski A. Age- and stimulus-dependent changes in anxiety-related behaviour of transgenic mice with GR dysfunction. Neuroreport 9 9 (1998) 2099-2102
44. Tronche F., Kellendonk C., Kretz O., Gass P., Anlag K., Orban P.C., Bock R., Klein R., and Schutz G. Disruption of the glucocorticoid receptor gene in the nervous system results in reduced anxiety. Nat. Genet. 23 1 (1999) 99-103
45. Tronche F., Kellendonk C., Reichardt H.M., and Schutz G. Genetic dissection of glucocorticoid receptor function in mice. Curr. Opin. Genet. Dev. 8 5 (1998) 532-538
46. Urani A., Chourbaji S., Henn F., and Gass P. The neurotrophin hypothesis of depression revistited by transgenic mice. Clin. Neurosci. Res. (2003)
47. van Rossum E.F., Binder E.B., Majer M., Koper J.W., Ising M., Modell S., Salyakina D., Lamberts S.W., and Holsboer F. Polymorphisms of the glucocorticoid receptor gene and major depression. Biol. Psychiatry 59 8 (2006) 681-688
48. von Bardeleben U., and Holsboer F. Effect of age on the cortisol response to human corticotropin-releasing hormone in depressed patients pretreated with dexamethasone. Biol. Psychiatry 29 10 (1991) 1042-1050
49. Wei Q., Lu X.Y., Liu L., Schafer G., Shieh K.R., Burke S., Robinson T.E., Watson S.J., Seasholtz A.F., and Akil H. Glucocorticoid receptor overexpression in forebrain: a mouse model of increased emotional lability. Proc. Natl. Acad. Sci. U. S. A. 101 32 (2004) 11851-11856
50. Wüst F., Carlson K.E., and Katzenellenbogen J.A. Synthesis of novel arylpyrazolo corticosteroids as potential ligands for imaging brain glucocorticoid receptors. Steroids 68 (2003) 177-191
51. Yehuda R. Are glucocorticoids responsible for putative hippocampal damage in PTSD? How and when to decide. Hippocampus 11 2 (2001) 85-89 discussion 82-84
52. Zobel A.W., Nickel T., Sonntag A., Uhr M., Holsboer F., and Ising M. Cortisol response in the combined dexamethasone/CRH test as predictor of relapse in patients with remitted depression. a prospective study. J. Psychiatr. Res. 35 2 (2001) 83-94